Delray Medical Center Performs County’s First Renal Denervation Procedure

Delray Medical Center became the first hospital in Palm Beach County to perform the Symplicity blood pressure procedure on Thursday offering a new catheter-based option for patients with persistent hypertension.

  • Targeted Nerves: The procedure uses radiofrequency energy to quiet overactive nerves near the kidneys that signal the body to raise blood pressure.
  • No Permanent Implant: Doctors insert a thin tube called a catheter into the kidney arteries, deliver the treatment, and remove the device entirely.
  • Additional Option: It is designed for individuals whose blood pressure remains high despite taking prescribed medications and following lifestyle modifications.

Dr. Gustavo Cardenas, a structural and interventional cardiologist, performed the milestone procedure at the 30-acre Palm Beach County facility, Florida Hospital News and Healthcare Report reported. The treatment utilizes the Medtronic Symplicity Spyral renal denervation system. This technology addresses the physiological mechanism where renal nerves hyperactivate, directly contributing to systemic hypertension.

During the intervention, the cardiologist guides a thin catheter into the renal arteries supplying each kidney. Controlled radiofrequency energy is then delivered to interrupt the overactive nerve pathways. Once the energy application concludes, the physician removes the catheter, leaving no hardware behind in the vascular system.

The U.S. Food and Drug Administration approved the Symplicity Spyral system in November 2023. Federal regulators cleared the device as an adjunctive treatment for patients whose blood pressure remains inadequately controlled despite optimal lifestyle changes and pharmacological therapy.

“When blood pressure remains high despite the steps a patient is already taking, it can be frustrating for them and their families,” Heather Havericak, CEO of Delray Medical Center, told Florida Hospital News and Healthcare Report.

Havericak said that the introduction of the technology expands local access to specialized cardiovascular care. “Dr. Cardenas and our cardiac team have brought another treatment option to those patients right here in Palm Beach County,” she told Florida Hospital News and Healthcare Report. “Being the first hospital in the county to offer this procedure reflects our investment in advanced cardiovascular care close to home.”

Medtronic, founded in 1949 in Minneapolis as a medical equipment repair shop, developed the world’s first battery-powered external pacemaker in 1957 after a Halloween power outage revealed the vulnerability of plug-in models.

The company, now headquartered in Ireland with operational headquarters in Minneapolis, employs over 90,000 people across more than 150 countries and is the largest medical device company in the world by revenue. Its history of firsts includes the implantable cardioverter-defibrillator and the world’s smallest pacemaker.

Procedure Element Clinical Detail
Device System Medtronic Symplicity Spyral™ renal denervation system
Milestone Date November 19, 2026
Primary Operator Dr. Gustavo Cardenas, structural and interventional cardiologist
Regulatory Status FDA approved in November 2023

Patients with hypertension who struggle to reach target blood pressure numbers through standard medications and lifestyle modifications should consult their primary physician or cardiologist. Medical professionals will evaluate individual vascular anatomy, kidney function, and secondary causes of hypertension to determine if the renal denervation procedure at Delray Medical Center is an appropriate clinical pathway.

Photo of author

Health Desk

Health Desk at Archyde.

Lukashenko Inspects Smorgoni Oil Plant, Orders Production Balance Review

Wiener Börse: ATX fällt 1,76 %; Wochenminus 5,84 %